A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1868-7083
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
A multicenter, randomized study of decitabine as epigenetic priming with induction chemotherapy in children with AML ; volume:9 ; number:1 ; day:5 ; month:10 ; year:2017 ; pages:1-13 ; date:12.2017
Clinical epigenetics ; 9, Heft 1 (5.10.2017), 1-13, 12.2017
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Gore, Lia
- Beteiligte Personen und Organisationen
-
Triche, Timothy J.
Farrar, Jason E.
Wai, Daniel
Legendre, Christophe
Gooden, Gerald C.
Liang, Winnie S.
Carpten, John
Lee, David
Alvaro, Frank
Macy, Margaret E.
Arndt, Carola
Barnette, Philip
Cooper, Todd
Martin, Laura
Narendran, Aru
Pollard, Jessica
Meshinchi, Soheil
Boklan, Jessica
Arceci, Robert J.
Salhia, Bodour
SpringerLink (Online service)
- DOI
-
10.1186/s13148-017-0411-x
- URN
-
urn:nbn:de:1111-201711301053
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Gore, Lia
- Triche, Timothy J.
- Farrar, Jason E.
- Wai, Daniel
- Legendre, Christophe
- Gooden, Gerald C.
- Liang, Winnie S.
- Carpten, John
- Lee, David
- Alvaro, Frank
- Macy, Margaret E.
- Arndt, Carola
- Barnette, Philip
- Cooper, Todd
- Martin, Laura
- Narendran, Aru
- Pollard, Jessica
- Meshinchi, Soheil
- Boklan, Jessica
- Arceci, Robert J.
- Salhia, Bodour
- SpringerLink (Online service)
Ähnliche Objekte (12)
Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Epigenetic synergy between decitabine and platinum derivatives
Epigenetic compound screening in AML with MNX1 overexpression
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Genetic and epigenetic profiles of elderly AML
Therapie von Patienten mit myeloischen Neoplasien (MDS und AML) mit der hypomethylierenden Substanz Decitabine
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER)
Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Epigenetic synergy between decitabine and platinum derivatives
Epigenetic compound screening in AML with MNX1 overexpression
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Genetic and epigenetic profiles of elderly AML
Therapie von Patienten mit myeloischen Neoplasien (MDS und AML) mit der hypomethylierenden Substanz Decitabine
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis
Activity of decitabine combined with all-trans retinoic acid in oligoblastic AML: Results from a randomized 2x2 phase II trial (DECIDER)
Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children
Epigenetic Anti‐Cancer Treatment With a Stabilized Carbocyclic Decitabine Analogue
Epigenetic synergy between decitabine and platinum derivatives
Epigenetic compound screening in AML with MNX1 overexpression
Epigenetic preconditioning with decitabine sensitizes glioblastoma to temozolomide via induction of MLH1
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Long-term decitabine/retinoic acid maintenance treatment in an elderly sAML patient with high-risk genetics
Reciprocal regulation of TWIST1 and OGT determines the decitabine efficacy in MDS/AML
Genetic and epigenetic profiles of elderly AML
Therapie von Patienten mit myeloischen Neoplasien (MDS und AML) mit der hypomethylierenden Substanz Decitabine
Venetoclax with decitabine versus decitabine monotherapy in elderly acute myeloid leukemia: a propensity score-matched analysis